CCL22 Signaling in the Tumor Environment.

Röhrle, Natascha; Knott, Max M L; Anz, David

Röhrle, Natascha; Knott, Max M L; Anz, David.

Afiliação

Röhrle N; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany.
Knott MML; Institute of Pathology of the Ludwig-Maximilians-Universität München, Munich, Germany.
Anz D; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany. d.anz@lmu.de.

Adv Exp Med Biol ; 1231: 79-96, 2020.

Article em En | MEDLINE | ID: mdl-32060848

Assuntos

Quimiocina CCL22/metabolismo; Neoplasias/imunologia; Neoplasias/metabolismo; Transdução de Sinais; Microambiente Tumoral; Animais; Humanos; Neoplasias/terapia; Receptores CCR4/metabolismo; Linfócitos T Reguladores/imunologia

Palavras-chave

Antitumor immunity; CCL22; CCR4; Chemokines; Dendritic cells; IL-1 α; Immune checkpoint; Immune escape; Immunosuppression; Immunotherapy; Lymph node; Prostaglandin E2; Regulatory T cells; T cell immunity; Tumor environment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Quimiocina CCL22 / Microambiente Tumoral / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google